image credit: Adobe Stock

Pharma partner Sartorius eyes gene therapy market with $2.6B deal

March 31, 2023

Sartorius, a Germany-based manufacturer and supplier to the biopharmaceutical industry, is acquiring France’s Polyplus in a $2.6 billion acquisition meant to expand the company’s role as partner to gene and cell therapy developers.

Under a deal announced Friday, Sartorius will buy the privately held Polyplus from owners that include the private equity firms Archimed and WP GG Holdings IV, an affiliate of Warburg Pincus. Pending approval by regulators and consultation with employee groups, the acquisition is expected to close in the third quarter.

Read More on Biopharma Dive